97 related articles for article (PubMed ID: 26235068)
1. Yeast as a Model for Alzheimer's Disease: Latest Studies and Advanced Strategies.
Verduyckt M; Vignaud H; Bynens T; Van den Brande J; Franssens V; Cullin C; Winderickx J
Methods Mol Biol; 2016; 1303():197-215. PubMed ID: 26235068
[TBL] [Abstract][Full Text] [Related]
2. Yeast as a Model for Studies on Aβ Aggregation Toxicity in Alzheimer's Disease, Autophagic Responses, and Drug Screening.
Porzoor A; Macreadie I
Methods Mol Biol; 2016; 1303():217-26. PubMed ID: 26235069
[TBL] [Abstract][Full Text] [Related]
3. Alzheimer's disease and amyloid: culprit or coincidence?
Skaper SD
Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
[TBL] [Abstract][Full Text] [Related]
4. Application of yeast to study the tau and amyloid-β abnormalities of Alzheimer's disease.
Porzoor A; Macreadie IG
J Alzheimers Dis; 2013; 35(2):217-25. PubMed ID: 23396350
[TBL] [Abstract][Full Text] [Related]
5. Amyloid-β peptide-induced cytotoxicity and mitochondrial dysfunction in yeast.
Chen X; Petranovic D
FEMS Yeast Res; 2015 Sep; 15(6):. PubMed ID: 26152713
[TBL] [Abstract][Full Text] [Related]
6. Alzheimer's disease: a general introduction and pathomechanism.
Finder VH
J Alzheimers Dis; 2010; 22 Suppl 3():5-19. PubMed ID: 20858960
[TBL] [Abstract][Full Text] [Related]
7. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
8. Mathematical model on Alzheimer's disease.
Hao W; Friedman A
BMC Syst Biol; 2016 Nov; 10(1):108. PubMed ID: 27863488
[TBL] [Abstract][Full Text] [Related]
9. Core biological marker candidates of Alzheimer's disease - perspectives for diagnosis, prediction of outcome and reflection of biological activity.
Hampel H; Mitchell A; Blennow K; Frank RA; Brettschneider S; Weller L; Möller HJ
J Neural Transm (Vienna); 2004 Mar; 111(3):247-72. PubMed ID: 14991453
[TBL] [Abstract][Full Text] [Related]
10. Accumulated amyloid-beta peptide and hyperphosphorylated tau protein: relationship and links in Alzheimer's disease.
Huang HC; Jiang ZF
J Alzheimers Dis; 2009; 16(1):15-27. PubMed ID: 19158417
[TBL] [Abstract][Full Text] [Related]
11. Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases.
Sasaki N; Fukatsu R; Tsuzuki K; Hayashi Y; Yoshida T; Fujii N; Koike T; Wakayama I; Yanagihara R; Garruto R; Amano N; Makita Z
Am J Pathol; 1998 Oct; 153(4):1149-55. PubMed ID: 9777946
[TBL] [Abstract][Full Text] [Related]
12. Endogenous murine tau promotes neurofibrillary tangles in 3xTg-AD mice without affecting cognition.
Baglietto-Vargas D; Kitazawa M; Le EJ; Estrada-Hernandez T; Rodriguez-Ortiz CJ; Medeiros R; Green KN; LaFerla FM
Neurobiol Dis; 2014 Feb; 62():407-15. PubMed ID: 24176788
[TBL] [Abstract][Full Text] [Related]
13. The heterogeneous nature of Cu2+ interactions with Alzheimer's amyloid-β peptide.
Drew SC; Barnham KJ
Acc Chem Res; 2011 Nov; 44(11):1146-55. PubMed ID: 21714485
[TBL] [Abstract][Full Text] [Related]
14. Mouse models of Alzheimer's disease: the long and filamentous road.
Phinney AL; Horne P; Yang J; Janus C; Bergeron C; Westaway D
Neurol Res; 2003 Sep; 25(6):590-600. PubMed ID: 14503012
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy for Alzheimer's disease.
Wang W; Fan L; Xu D; Wen Z; Yu R; Ma Q
Acta Biochim Biophys Sin (Shanghai); 2012 Oct; 44(10):807-14. PubMed ID: 22899646
[TBL] [Abstract][Full Text] [Related]
16. Recent Insights on Alzheimer's Disease Originating from Yeast Models.
Seynnaeve D; Vecchio MD; Fruhmann G; Verelst J; Cools M; Beckers J; Mulvihill DP; Winderickx J; Franssens V
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29970827
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy for Alzheimer's disease: from anti-β-amyloid to tau-based immunization strategies.
Panza F; Frisardi V; Solfrizzi V; Imbimbo BP; Logroscino G; Santamato A; Greco A; Seripa D; Pilotto A
Immunotherapy; 2012 Feb; 4(2):213-38. PubMed ID: 22339463
[TBL] [Abstract][Full Text] [Related]
18. [Advances in molecular biology and clinical study of amyloid precursor protein for Alzheimer's disease].
Xu BG; Wu X
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr; 26(2):201-9. PubMed ID: 15171563
[TBL] [Abstract][Full Text] [Related]
19. Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis.
Bloom GS
JAMA Neurol; 2014 Apr; 71(4):505-8. PubMed ID: 24493463
[TBL] [Abstract][Full Text] [Related]
20. Amyloid precursor protein cytoplasmic domain with phospho-Thr668 accumulates in Alzheimer's disease and its transgenic models: a role to mediate interaction of Abeta and tau.
Shin RW; Ogino K; Shimabuku A; Taki T; Nakashima H; Ishihara T; Kitamoto T
Acta Neuropathol; 2007 Jun; 113(6):627-36. PubMed ID: 17431643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
